Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dendritic cell endocytic uptake machinery refers to a complex network of surface receptors and intracellular pathways that allow dendritic cells (DCs) to capture, internalize, and process antigens from the extracellular environment. This machinery primarily includes C-type lectin receptors (such as DEC-205, DC-SIGN, and the Mannose receptor), Fc receptors, and scavenger receptors, which facilitate receptor-mediated endocytosis and phagocytosis (3.2.1, 3.2.3). Once internalized, antigens are directed to specialized endosomal and lysosomal compartments where they are proteolytically cleaved into peptides and loaded onto MHC class I or II molecules for presentation to T cells (3.2.4, 3.2.5). This process is critical for the initiation of adaptive immune responses against pathogens and tumors, as well as for the maintenance of peripheral tolerance to self-antigens (3.1.1, 3.2.2). In therapeutic contexts, this machinery is targeted by antibody-antigen conjugates and nanoparticle-based delivery systems to enhance vaccine efficacy or induce antigen-specific tolerance in autoimmune diseases (3.1.1, 3.2.1). For example, targeting DEC-205 with antibody-antigen conjugates can lead to robust T-cell activation when combined with maturation signals, while targeting the same receptors in a steady state can promote tolerance (3.2.1, 3.2.3). Challenges in targeting this system include ensuring proper DC maturation to avoid unintended tolerance and managing off-target effects on other myeloid cells that share these endocytic receptors (3.1.1, 3.2.2).
Facilitates the internalization of antigens via receptor-mediated endocytosis or phagocytosis, directing them to MHC-I and MHC-II processing pathways to initiate T-cell responses or induce tolerance.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dendritic cell endocytic uptake machinery.